20 June 2022>: Clinical Research
A Single-Center Retrospective Study to Compare the Efficacy and Safety of Modified FOLFIRINOX with S-1 as Adjuvant Chemotherapy in 71 Patients with Resected Pancreatic Carcinoma
Linhua Yao 1ABCEF , Chengwu Tang 2ABCEF , Wenming Feng 2ABFG , Hanbin Dai 2ABCE*DOI: 10.12659/MSM.937136
Med Sci Monit 2022; 28:e937136
Table 3 Sites of first relapse.
Site | S-1 group | mFFX group |
---|---|---|
Local | 9 | 8 |
Liver | 6 | 5 |
Abdominal lymph node | 5 | 5 |
Peritoneum | 3 | 3 |
Lung | 2 | 1 |
Others | 1 | 1 |